One Equity Partners Vies for Turkish Chemical Company

One Equity Partners, the main private equity arm of JPMorgan, and Turkish army pension fund Oyak are vying to buy a stake in Turkish chemicals maker Akdeniz Kimya, sources told Reuters. Akdeniz Kimya, based in the Aegean coastal city of Izmir, produces speciality chemicals and is valued at more than $300 million. It was not clear how large a stake is up for sale.

(Reuters) – One Equity Partners, the main private equity arm of JPMorgan, and Turkish army pension fund Oyak are vying to buy a stake in Turkish chemicals maker Akdeniz Kimya, sources close to the matter told Reuters.

Akdeniz Kimya, based in the Aegean coastal city of Izmir, produces speciality chemicals and is valued at more than $300 million. It was not clear how large a stake is up for sale.

Two of the sources said a deal would be signed this year.

Citigroup has been mandated to handle the sale, the sources said.

Officials from One Equity Partners and Akdeniz Kimya were not immediately available to comment. Oyak declined to comment.

Related Posts

Leave a Reply

PEHUB Community

Join the 12503 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

PE HUB News Briefs

RSS Feed Widget

Marketplace

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget

Reuters VC and PE feed

RSS Feed Widget